FDA Inspection
MDG MedicalMDG Medical – FDA Inspection, Nov 22, 2017
Record Details
This FDA Inspection record concerns MDG Medical, with an inspection on November 22, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 36a2f57f-8885-4d41-a02c-fb14051a3868
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1034762
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 1271.265(a)Evaluation--microorganisms, damage
- 21 CFR 1271.180(a)Procedures to meet core CTGP
Full citation text and observation details available on the Dashboard.
Other FDA inspections of MDG Medical
1| Date | Classification | Office | Project area |
|---|---|---|---|
| November 5, 2019 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for MDG Medical
- FDA Inspection 1110080 - 2019-11-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.